Phase1
at Orion Corporation
Turku, Etelä-Suomi, Finland -
Start Date | Expiry Date | Salary | Posted On | Experience | Skills | Telecommute | Sponsor Visa |
---|---|---|---|---|---|---|---|
Immediate | 01 May, 2025 | Not Specified | 01 Feb, 2025 | N/A | Molecular Biology,English,Cell Biology,Biochemistry,Communication Skills,Health Sciences | No | No |
Required Visa Status:
Citizen | GC |
US Citizen | Student Visa |
H1B | CPT |
OPT | H4 Spouse of H1B |
GC Green Card |
Employment Type:
Full Time | Part Time |
Permanent | Independent - 1099 |
Contract – W2 | C2H Independent |
C2H W2 | Contract – Corp 2 Corp |
Contract to Hire – Corp 2 Corp |
Description:
Phase1 is Orion’s paid trainee program for university and university of applied sciences students. The program brings together a large group of trainees from different disciplines. In addition to summer jobs, the program offers various events, networking with other trainees and Orionees, and group mentoring to support your career! Could this be the first phase of your Orion career? For more information about the Phase1 trainee program and the application process, please visit Orion’s website.
DESCRIPTION OF THE POSITION
The Antibody-Drug Conjugates (ADC; one position) and Immuno-oncology (IO, one position) units are looking for highly motivated students with a strong background in cell biology to work as a Phase1 R&D-trainee during the summer of 2025. You will support early-stage drug discovery as a part of a unit focusing on target identification, validation, and mechanism of action studies. You will do hands-on laboratory work such as mammalian cell culture and related assays as well as participate in daily laboratory maintenance under the supervision of scientists and experienced research assistants. The position is placed in the research laboratories in Turku.
DESCRIPTION OF THE UNITS
Antibody-Drug Conjugates (ADC) unit is one of three Research teams in Orion’s Oncology R&D. Antibody-drug conjugates are a class of biopharmaceutical targeted therapy drugs for treating cancer. The ADC unit is accountable for novel drug discovery projects and the identification and validation of potential ADC drug targets with state-of-the-art technologies. Immuno-Oncology (IO) is one of the three Research teams in Orion’s Oncology R&D. IO team is accountable for novel drug discovery projects, identification of unmet need, identification & experimental validation of potential IO drug targets within state-of-the-art laboratories and technologies
REQUIREMENTS
A successful applicant has hands-on experience of laboratory work and previous experience in working in a mammalian cell culture laboratory. Additionally, we expect that you have completed at least 3 years of university studies in the field of health sciences (for example cell biology, molecular biology or biochemistry). You are a highly motivated and accurate professional with good communication skills in English and the ability to interact in a collaborative work environment.
#LI-DNI
Orion Corporation operates in more than 30 countries, where we Orionees, 3600 in total, work in all kinds of positions. Among us there are Research Scientists, Laboratory Technicians, Engineers and IT Specialists as well as people working in Production, just to mention some examples. We offer diverse and responsible jobs to our personnel in a truly multi-disciplinary work environment. We encourage people to develop their competences and offer opportunities to affect the job description and creating their own career path at Orion. We are searching for top talents who are ready to share our passion for the work that we do
Responsibilities:
Please refer the Job description for details
REQUIREMENT SUMMARY
Min:N/AMax:5.0 year(s)
Hospital/Health Care
Pharma / Biotech / Healthcare / Medical / R&D
Health Care
Graduate
Proficient
1
Turku, Finland